A Phase III clinical trial evaluating the first-line treatment of advanced non-small cell lung cancer with PD-1 inhibitors combined with chemotherapy
Project Title: Phase III Clinical Study Evaluating the Efficacy and Safety of QL1706 Combined with Chemotherapy as First-Line Treatment for Patients with PD-L1 Negative, Locally Advanced, or Metastatic Non-Small Cell Lung Cancer